Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Fernandez TL"'
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants.
Autor: Westendorf K; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Žentelis S; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Wang L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Foster D; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Vaillancourt P; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Wiggin M; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Lovett E; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., van der Lee R; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Hendle J; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Pustilnik A; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Sauder JM; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Kraft L; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Hwang Y; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Siegel RW; Eli Lilly and Company, Indianapolis, IN 46285, USA., Chen J; Eli Lilly and Company, Indianapolis, IN 46285, USA., Heinz BA; Eli Lilly and Company, Indianapolis, IN 46285, USA., Higgs RE; Eli Lilly and Company, Indianapolis, IN 46285, USA., Kallewaard NL; Eli Lilly and Company, Indianapolis, IN 46285, USA., Jepson K; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Goya R; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Smith MA; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Collins DW; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Pellacani D; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Xiang P; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., de Puyraimond V; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Ricicova M; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Devorkin L; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Pritchard C; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., O'Neill A; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Dalal K; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Panwar P; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Dhupar H; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Garces FA; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Cohen CA; U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD 21702, USA., Dye JM; U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD 21702, USA., Huie KE; U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD 21702, USA., Badger CV; U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, MD 21702, USA., Kobasa D; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3L5, Canada; University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Audet J; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3L5, Canada; University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Freitas JJ; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Hassanali S; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Hughes I; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Munoz L; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Palma HC; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Ramamurthy B; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA., Cross RW; University of Manitoba, Winnipeg, MB R3T 2N2, Canada; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Geisbert TW; University of Manitoba, Winnipeg, MB R3T 2N2, Canada; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Menachery V; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Lokugamage K; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Borisevich V; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Lanz I; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Anderson L; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Sipahimalani P; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Corbett KS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Yang ES; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Zhang Y; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Shi W; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Zhou T; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Choe M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Misasi J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Fernandez TL; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Hansen CL; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Falconer E; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Jones BE; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA. Electronic address: jones_bryan_edward@lilly.com., Barnhart BC; AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada. Electronic address: bo.barnhart@abcellera.com.
Publikováno v: Cell reports [Cell Rep] 2022 May 17; Vol. 39 (7), pp. 110812. Date of Electronic Publication: 2022 Apr 25.
Zobrazit plný text záznamu
4
Akademický článek
COVID-19 Vaccinations: Perceptions and Behaviours in People with Primary Ciliary Dyskinesia.
Autor: Pedersen ESL; Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland., Mallet MC; Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland.; Graduate School for Health Sciences, University of Bern, 3012 Bern, Switzerland., Lam YT; Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland., Bellu S; Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kartagener Onlus, 70124 Bari, Italy., Cizeau I; Association ADCP, 42218 Saint-Étienne, France., Copeland F; PCD Support UK, London MK18 9DX, UK., Fernandez TL; Asociación Española de Pacientes con Discinesia Ciliar Primaria, Santo Ángel 30151, Philippines., Manion M; PCD Foundation, Minneapolis, MN 55420, USA., Harris AL; Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK., Lucas JS; Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.; Faculty of Medicine, School of Clinical and Experimental Medicine, University of Southampton, Southampton SO17 1BJ, UK., Santamaria F; Department of Translational Medical Sciences, Federico II University, 80138 Naples, Italy., Goutaki M; Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland.; Division of Paediatric Respiratory Medicine and Allergology, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Kuehni CE; Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland.; Division of Paediatric Respiratory Medicine and Allergology, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Covid-Pcd Patient Advisory Group
Publikováno v: Vaccines [Vaccines (Basel)] 2021 Dec 17; Vol. 9 (12). Date of Electronic Publication: 2021 Dec 17.
Zobrazit plný text záznamu
5
Akademický článek
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy.
Autor: Gregorietti V; Cardio-Oncology Department, Roffo Institute, 5481 Av San Martin. CABA,, Buenos Aires, Argentina., Fernandez TL; Cardiology Department, La Paz University Hospital, Madrid, Spain., Costa D; Cardio-Oncology Department, Roffo Institute, 5481 Av San Martin. CABA,, Buenos Aires, Argentina., Chahla EO; Cardio-Oncology Department, Roffo Institute, 5481 Av San Martin. CABA,, Buenos Aires, Argentina., Daniele AJ; Cardio-Oncology Department, Roffo Institute, 5481 Av San Martin. CABA,, Buenos Aires, Argentina. ajdaniele@gmail.com.
Publikováno v: Cardio-oncology (London, England) [Cardiooncology] 2020 Nov 05; Vol. 6 (1), pp. 24. Date of Electronic Publication: 2020 Nov 05.
Zobrazit plný text záznamu
6
Akademický článek
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Autor: Pudil R; 1st Department Medicine - Cardioangiology, Charles University Prague, Medical Faculty and University Hospital Hradec Kralove, Prague, Czech Republic., Mueller C; Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland., Čelutkienė J; Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.; State Research Institute Centre For Innovative Medicine, Vilnius, Lithuania., Henriksen PA; Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK., Lenihan D; Cardio-Oncology Center of Excellence, Washington University in St Louis, St Louis, MO, USA., Dent S; Duke Cancer Institute, Duke University, Durham, NC, USA., Barac A; MedStar Heart and Vascular Institute, Georgetown University, Washington, DC, USA., Stanway S; Breast Unit, Royal Marsden Hospital, Surrey, UK., Moslehi J; Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Suter TM; Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland., Ky B; University of Pennsylvania, Philadelphia, PA, USA., Štěrba M; Department of Pharmacology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Cardinale D; Cardioncology Unit, European Institute of Oncology, IRCCS, Milan, Italy., Cohen-Solal A; UMR-S 942, Paris University, Cardiology Department, Lariboisiere Hospital, AP-HP, Paris, France., Tocchetti CG; Department of Translational Medical Sciences and Interdepartmental Center for Clinical and Translational Research (CIRCET), 'Federico II' University, Naples, Italy., Farmakis D; University of Cyprus Medical School, Nicosia, Cyprus.; Cardio-Oncology Clinic, Heart Failure Unit, 'Attikon' University Hospital, Athens, Greece.; National and Kapodistrian University of Athens Medical School, Athens, Greece., Bergler-Klein J; Department of Cardiology, Medical University of Vienna, Vienna, Austria., Anker MS; Division of Cardiology and Metabolism, Department of Cardiology, Charité and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research), partner site Berlin and Department of Cardiology, Charité Campus Benjamin Franklin, Berlin, Germany., Von Haehling S; Department of Cardiology and Pneumology, University of Goettingen Medical Center, Goettingen, Germany.; German Center for Cardiovascular Research (DZHK), partner site Goettingen, Goettingen, Germany., Belenkov Y; Sechenov Medical University, Moscow, Russia., Iakobishvili Z; Department of Community Cardiology, Tel Aviv Jaffa District, Clalit Health Fund and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Maack C; Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany., Ciardiello F; Department of Precision Medicine, 'Luigi Vanvitelli' University of Campania, Naples, Italy., Ruschitzka F; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland., Coats AJS; University of Warwick, Warwick, UK.; Pharmacology Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana, Rome, Italy., Seferovic P; Faculty of Medicine and Serbian Academy of Sciences and Arts, University of Belgrade, Belgrade, Serbia., Lainscak M; University of Ljubljana, Ljubljana, Slovenia., Piepoli MF; Cardiac Department, 'Guglielmo da Saliceto' Polichirurgico Hospital AUSL Piacenza, Piacenza, Italy., Chioncel O; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.; University of Medicine Carol Davila, Bucharest, Romania., Bax J; Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands., Hulot JS; Université de Paris, CIC1418, Paris Cardiovascular Research Center, INSERM, Paris, France., Skouri H; Cardiology Division, Internal Medicine Department at American University of Beirut Medical Center, Beirut, Lebanon., Hägler-Laube ES; Inselspital, University Hospital of Bern, Bern, Switzerland., Asteggiano R; Cardiologist in Practice, Turin, Italy., Fernandez TL; Cardiology Service, Cardio-Oncology Unit, La Paz University Hospital and IdiPAz Research Institute, Ciber CV, Madrid, Spain., de Boer RA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lyon AR; Cardio-Oncology Service, Royal Brompton Hospital and Imperial College London, London, UK.
Publikováno v: European journal of heart failure [Eur J Heart Fail] 2020 Nov; Vol. 22 (11), pp. 1966-1983. Date of Electronic Publication: 2020 Oct 20.
Zobrazit plný text záznamu
7
Akademický článek
Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation.
Autor: Petrus P; Karolinska Institutet, Stockholm, Sweden., Fernandez TL; Centre for Blood Research, Life Sciences Institute, Department of Medicine, University of British Columbia, Vancouver, Canada., Kwon MM; Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Huang JL; Centre for Blood Research, Life Sciences Institute, Department of Medicine, University of British Columbia, Vancouver, Canada., Lei V; Centre for Blood Research, Life Sciences Institute, Department of Medicine, University of British Columbia, Vancouver, Canada., Safikhan NS; Centre for Blood Research, Life Sciences Institute, Department of Medicine, University of British Columbia, Vancouver, Canada., Karunakaran S; Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada., O'Shannessy DJ; Morphotek Inc., Exton, PA, USA., Zheng X; Karolinska Institutet, Stockholm, Sweden., Catrina SB; Karolinska Institutet, Stockholm, Sweden., Albone E; Morphotek Inc., Exton, PA, USA., Laine J; University of Turku, Finland., Virtanen K; University of Turku, Finland., Clee SM; Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Kieffer TJ; Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Noll C; Division of Endocrinology, Department of Medicine, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke, Canada., Carpentier AC; Division of Endocrinology, Department of Medicine, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke, Canada., Johnson JD; Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Rydén M; Karolinska Institutet, Stockholm, Sweden. Electronic address: mikael.ryden@ki.se., Conway EM; Centre for Blood Research, Life Sciences Institute, Department of Medicine, University of British Columbia, Vancouver, Canada. Electronic address: ed.conway@ubc.ca.
Publikováno v: EBioMedicine [EBioMedicine] 2019 Jun; Vol. 44, pp. 489-501. Date of Electronic Publication: 2019 Jun 17.
Zobrazit plný text záznamu
9
Report
Insulin-like growth factor-I and UVB photoprotection in human keratinocytes.
Autor: Fernandez TL; Tissue Repair and Regeneration Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Qld, Australia., Van Lonkhuyzen DR, Dawson RA, Kimlin MG, Upton Z
Publikováno v: Experimental dermatology [Exp Dermatol] 2015 Mar; Vol. 24 (3), pp. 235-8.
Zobrazit plný text záznamu
10
Akademický článek
In vitro investigations on the effect of dermal fibroblasts on keratinocyte responses to ultraviolet B radiation.
Autor: Fernandez TL; Tissue Repair and Regeneration Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Qld, Australia., Van Lonkhuyzen DR, Dawson RA, Kimlin MG, Upton Z
Publikováno v: Photochemistry and photobiology [Photochem Photobiol] 2014 Nov-Dec; Vol. 90 (6), pp. 1332-9. Date of Electronic Publication: 2014 Aug 19.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje